L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-life mobility insights from wearable sensors Alessandro Zampogna, Luigi Borzì, Domiziana Rinaldi, Gabriele Imbalzano, Martina Patera, Marco Falletti, Carlo Alberto Artusi, Edoardo Bianchini, Leonardo Lopiano, Gabriella Olmo, Antonio Suppa Frontiers in Neurology.2026;[Epub] CrossRef
Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The Role of Standard Screening Measures and Wearable-Data Victor J. Geraedts, Jeroen P.P. van Vugt, Johan Marinus, Roy Kuiper, Huub A.M. Middelkoop, Rodi Zutt, Niels A. van der Gaag, Carel F.E. Hoffmann, Lucille D.A. Dorresteijn, Jacobus J. van Hilten, Maria Fiorella Contarino Journal of Parkinson’s Disease.2023; 13(4): 575. CrossRef
Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, Shadab Md, Nabil A. Alhakamy, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Mohammad Zaki Ahmad, Awanish Mishra Biochemical Pharmacology.2022; 195: 114849. CrossRef